Orthofix Medical Inc. announced that Massimo Calafiore has been named incoming President. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate?s previously announced acquisition by Enovis Corporation. At that time, Mr. Calafiore is also expected to join Orthofix?s Board of Directors.

Mr. Calafiore is an accomplished global business leader with an excellent track record across multiple companies in the orthopedics and spine industry. Throughout his career he has demonstrated a commitment to operating excellence, ethical integrity and DE&I values. He has been CEO of LimaCorporate since September 2022.

During this time, Mr. Calafiore strengthened and reshaped the company?s strategy and culture priorities, with an emphasis on fostering, mentoring and retaining talent. His leadership resulted in consecutive quarter-over-quarter above-market growth; best-in-class EBITDA margins; and substantial improvement in employee engagement and retention. On September 25, 2023, LimaCorporate announced its sale to Enovis Corporation for ?800 million.

Prior to LimaCorporate, he served as Executive Vice President and Chief Commercial Officer of NuVasive Inc. and delivered consecutive quarter-over-quarter above-market growth in all core geographies, including the U.S., APAC, EMEA and Japan, and successfully launched multiple products globally, which became foundational to NuVasive?s portfolio offering. At the beginning of his tenure at NuVasive, Mr. Calafiore served as President of NuVasive Specialized Orthopedics (formerly Ellipse Technologies). In this role, he helped to further integrate the Ellipse business with NuVasive, achieving multiple quarters of accelerated revenue growth with above-market operation margin expansion.

NuVasive Specialized Orthopedics is an important player in complex trauma and limb reconstruction for adults and children, a market segment where Orthofix is also a recognized leader. Earlier in his career, Mr. Calafiore worked for Waldemar Link GmbH & Co. KG and served in various leadership roles across multiple business segments, including orthopedics, lower extremities and spine.

He oversaw the sales of the STAR Ankle to Small Bone Innovations and the PCM Cervical disc to NuVasive. He holds an M.Sc. in Mechanical Engineering from the University of Catania and an MBA from New York University.

The Company also announced that Ms. Burzik has notified the Board that she has elected to not stand for reelection to the Board at the 2024 Annual Meeting.